このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

A Comprehensive Psychometric Validation of EQ Instruments for Early Childhood Health-Related Quality of Life and Caregiver Spillover

2026年11月10日 更新者:Wenjing Zhou、RenJi Hospital

A Comprehensive Psychometric Validation of EQ Instruments for Early Childhood Health-Related Quality of Life and Caregiver Spillover, Including EQ-TIPS, EQ-5D-Y-5L, EQ-5D-5L With Sleep and Fatigue Bolt-ons, and the EQ-HWB-9

This study aims to address critical gaps in the measurement of health-related quality of life (HRQoL) in children under the age of five by conducting a comprehensive psychometric validation of the EQ-TIPS instrument, including both 3-level and 5-level versions. We will conduct a longitudinal study using both quantitative and qualitative methods to assess the feasibility, face validity, known-groups validity, test-retest reliability, and responsiveness of both EQ-TIPS-3L and EQ-TIPS-5L in children aged 0-48 months. For children aged 25-48 months, we will also examine the comparability and potential transition between EQ-TIPS-5L and the proxy version of EQ-5D-Y-5L. In addition, we aim to explore spillover effects on family carers by evaluating the psychometric performance, such as known-groups validity, test-retest reliability, and responsiveness of two newly developed EQ-5D-5L bolt-on items (sleep and fatigue) and the EQ-HWB-9. A total of 450 participants will be recruited from three tertiary hospitals in China across three health condition groups: acute illnesses (n=180), chronic conditions (n=180), and healthy controls (n=90), with an approximately balanced distribution across age groups and disease severity levels. The survey questionnaires will include two parts: 1) Child section: EQ-TIPS-3L, EQ-TIPS-5L, proxy EQ VAS, EQ-5D-Y-5L proxy version 1 (only for children aged 25-48 months), a 5-grade overall health assessment (OHA) proxy version, QQ-10 questionnaire, and children's demographic information; 2) Carer section: carers' EQ-5D-5L with sleep and fatigue bolt-ons, carers' EQ VAS, carers' EQ-HWB-9, and carers' demographic information. Each clinical condition is selected for its high prevalence and clinical relevance in early childhood, as well as its suitability for stratifying health status by severity. Additionally, to assess face validity, carers will complete the QQ-10 questionnaire after completing the EQ-TIPS questionnaire to provide structured feedback on the clarity, relevance, and acceptability of EQ-TIPS. Findings will contribute essential evidence to support the use of EQ-TIPS in early childhood HRQoL assessment and of the EQ-5D-5L bolt-ons and EQ-HWB-9 in evaluating caregiver spillover effects. The study data will be shared with the EuroQol Group to support future development and application of these instruments.

調査の概要

研究の種類

観察的

入学 (推定)

450

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

1秒~4年 (子)

健康ボランティアの受け入れ

はい

受講資格のある性別

全て

サンプリング方法

非確率サンプル

調査対象母集団

The study population will consist of 450 children aged 0-48 months and their primary family carers recruited from three tertiary hospitals in China. Participants will be enrolled into three groups: acute illnesses (pneumonia and diarrhoea, n=180), chronic conditions (haematological malignancies and asthma, n=180), and healthy controls (n=90). Recruitment will aim for balanced representation across age groups (0-24 and 25-48 months) and disease severity levels. Children with illnesses will be recruited from outpatient clinics and inpatient departments, while healthy controls will be recruited during routine physical examinations. Primary family carers will serve as proxy respondents for child health assessments and complete questionnaires assessing their own health and well-being.

説明

Inclusion Criteria:

  • -Children aged 0-48 months at enrolment.
  • Children diagnosed with pneumonia, acute diarrhoea, haematological malignancies, or asthma; or healthy children without known medical conditions attending routine physical examinations.
  • Availability of a primary family carer (parent, grandparent, or legal guardian) who has primarily cared for the child during the preceding month, including supervision of daily activities and health-related care.
  • The primary family carer accompanies the child during the outpatient visit, inpatient admission, or routine physical examination.
  • The primary family carer is able to understand the study information and provides written informed consent.

Exclusion Criteria:

  • Children older than 48 months at enrolment.
  • Primary family carers unable to read or understand Chinese.
  • Primary family carers with cognitive impairments that prevent questionnaire completion.
  • Absence of written informed consent.

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか?

デザインの詳細

  • 観測モデル:COHORT
  • 時間の展望:PROSPECTIVE

コホートと介入

グループ/コホート
介入・治療
Acute Illness Group

Children aged 0-48 months diagnosed with acute illnesses, including pneumonia (n=90) and acute diarrhoea (n=90). Participants will be recruited across different disease severity levels. Their primary family carers will complete proxy-reported health-related quality of life assessments at baseline and follow-up, while also reporting their own health and well-being.

This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study.

Chronic Illness Group

Children aged 0-48 months diagnosed with chronic conditions, including haematological malignancies (n=90) and asthma (n=90). Participants will represent different levels of disease severity. Their primary family carers will complete proxy-reported health-related quality of life assessments at baseline and follow-up, alongside assessments of their own health and caregiver spillover effects

This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study.

Healthy Control Group

Group/Cohort Description:

Age-matched healthy children aged 0-48 months (n=90), with no known medical conditions at the time of assessment, recruited during routine physical examinations. Their primary family carers will complete the same proxy-reported child health and caregiver health-related quality of life assessments as those in the illness groups.

This study involves longitudinal health-related quality of life assessments of children aged 0-48 months and their primary family carers. Carers will complete the EQ-TIPS-3L and EQ-TIPS-5L as proxy respondents for their children. For children aged 25-48 months, the proxy EQ-5D-Y-5L will also be administered. Carers will additionally complete the EQ-5D-5L with sleep and fatigue bolt-on items and the EQ-HWB-9 to assess caregiver spillover effects. Assessments will be conducted at baseline and follow-up using tablet-based questionnaires. No therapeutic interventions will be assigned as part of the study.

この研究は何を測定していますか?

主要な結果の測定

結果測定
メジャーの説明
時間枠
Known-Groups Validity of EQ-TIPS-3L and EQ-TIPS-5L
時間枠:Baseline

Known-groups validity will be evaluated by comparing EQ-TIPS-3L and EQ-TIPS-5L level sum scores (LSS) across predefined clinical severity categories and overall health assessment (OHA) categories. Cohen's d and relative efficiency based on ANOVA F-statistics will be calculated to assess the instruments' discriminatory ability.

Baseline
Test-Retest Reliability of EQ-TIPS-3L and EQ-TIPS-5L
時間枠:Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

Test-retest reliability will be evaluated among children whose health status remains stable between baseline and follow-up, as determined by unchanged clinical severity and overall health assessment (OHA). Intraclass correlation coefficients (ICCs) will be calculated for EQ-TIPS level sum scores (LSS), and Gwet's agreement coefficients will be calculated for individual dimensions.

Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
Responsiveness of EQ-TIPS-3L and EQ-TIPS-5L to Changes in Child Health
時間枠:Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

Responsiveness will be evaluated by changes in EQ-TIPS-3L and EQ-TIPS-5L scores between baseline and follow-up among children classified as improved, stable, or deteriorated based on clinical indicators and overall health assessment (OHA). Standardised effect size (SES), standardised response mean (SRM), and Paretian Classification of Health Change (PCHC) will be calculated.

Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

二次結果の測定

結果測定
メジャーの説明
時間枠
Face Validity and Acceptability of EQ-TIPS-3L and EQ-TIPS-5L
時間枠:Baseline

Face validity and acceptability will be assessed using the QQ-10 questionnaire completed by family carers. Quantitative responses will evaluate perceived value, clarity, relevance, and acceptability. Open-ended responses will undergo thematic content analysis to identify concerns regarding comprehensiveness, redundancy, and questionnaire burden.

Baseline
Comparative Psychometric Performance of EQ-TIPS-3L and EQ-TIPS-5L
時間枠:Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

EQ-TIPS-3L and EQ-TIPS-5L will be compared in terms of missing responses, response distributions, ceiling effects, known-groups validity, test-retest reliability, and responsiveness to health change. Ceiling effects will be assessed using the proportion of children reporting no problems across all dimensions.

Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)
Psychometric Performance of EQ-5D-5L With Sleep and Fatigue Bolt-Ons and EQ-HWB-9 in Family Carers
時間枠:Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

Caregiver outcomes will be evaluated using EQ-5D-5L with sleep and fatigue bolt-on items and EQ-HWB-9. Analyses will assess response distributions, ceiling effects, known-groups validity, test-retest reliability, and responsiveness to changes in child health. Regression analyses will explore associations with child disease severity, caregiving time, and caregiver burden.

Baseline and follow-up (at least 3 days after baseline; timing varies by clinical condition)

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

出版物と役立つリンク

研究に関する情報を入力する責任者は、自発的にこれらの出版物を提供します。これらは、研究に関連するあらゆるものに関するものである可能性があります。

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年12月10日

一次修了 (推定)

2027年12月10日

研究の完了 (推定)

2028年12月9日

試験登録日

最初に提出

2026年11月10日

QC基準を満たした最初の提出物

2026年11月10日

最初の投稿 (実際)

2026年11月16日

学習記録の更新

投稿された最後の更新 (実際)

2026年11月16日

QC基準を満たした最後の更新が送信されました

2026年11月10日

最終確認日

2026年11月1日

詳しくは

本研究に関する用語

個々の参加者データ (IPD) の計画

個々の参加者データ (IPD) を共有する予定はありますか?

未定

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する